Explore more publications!
North Carolina Wellness News
Got News to Share?

North Carolina Wellness News: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on North Carolina Wellness News.

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

January 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

February 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28

Press releases published on January 20, 2026

Orphai Therapeutics’ Phase 2a LAM-001 Study Selected for Oral Presentation at the American Thoracic Society (ATS) 2026 International Conference
Jan. 20, 2026

Orphai Therapeutics’ Phase 2a LAM-001 Study Selected for Oral Presentation at the American Thoracic Society (ATS) 2026 International Conference

Indeterminate GlobeNewswire
MAIA Biotechnology Advances Ateganosine Cancer Treatment Program, Outlines Targeted 2026 Clinical Milestones and Growth Momentum
Jan. 20, 2026

MAIA Biotechnology Advances Ateganosine Cancer Treatment Program, Outlines Targeted 2026 Clinical Milestones and Growth Momentum

Indeterminate GlobeNewswire
Comfort Keepers Ireland Highlights Urgent Need for Scaling Safe, Regulated Home Support
Jan. 20, 2026

Comfort Keepers Ireland Highlights Urgent Need for Scaling Safe, Regulated Home Support

Indeterminate GlobeNewswire
Adaptin Bio Advances Novel Brain Cancer Treatment Candidate Towards Phase 1 Glioblastoma Clinical Trial
Jan. 20, 2026

Adaptin Bio Advances Novel Brain Cancer Treatment Candidate Towards Phase 1 Glioblastoma Clinical Trial

Indeterminate GlobeNewswire
First-of-its-kind Trojan Horse Cancer Treatment Approved for Clinical Trials
Jan. 20, 2026

First-of-its-kind Trojan Horse Cancer Treatment Approved for Clinical Trials

Indeterminate GlobeNewswire
Methyl Cellulose Market worth $5.88 billion by 2030, at a CAGR of 10.0%, says MarketsandMarkets™
Jan. 20, 2026

Methyl Cellulose Market worth $5.88 billion by 2030, at a CAGR of 10.0%, says MarketsandMarkets™

Indeterminate GlobeNewswire
New National Report: Nurse-Led Coordination Strengthens Patient Access, Reduces Delays and Improves Throughput Across U.S. Health Systems
Jan. 20, 2026

New National Report: Nurse-Led Coordination Strengthens Patient Access, Reduces Delays and Improves Throughput Across U.S. Health Systems

Indeterminate GlobeNewswire
Capricor Therapeutics Provides Regulatory Update on Deramiocel BLA Following FDA Review of HOPE-3 Topline Data
Jan. 20, 2026

Capricor Therapeutics Provides Regulatory Update on Deramiocel BLA Following FDA Review of HOPE-3 Topline Data

Indeterminate GlobeNewswire
TOMI Environmental Solutions Secures UK CES contract integrating SteraMist iHP into Total Clean Air's Modular Cleanroom Platform
Jan. 20, 2026

TOMI Environmental Solutions Secures UK CES contract integrating SteraMist iHP into Total Clean Air's Modular Cleanroom Platform

Indeterminate GlobeNewswire
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Jan. 20, 2026

InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
New Imprivata Survey Finds 85% of Healthcare IT Leaders Think Passwordless Authentication is Vital, but Adoption Lags Significantly
Jan. 20, 2026

New Imprivata Survey Finds 85% of Healthcare IT Leaders Think Passwordless Authentication is Vital, but Adoption Lags Significantly

Indeterminate GlobeNewswire
SPARK NS and Haukeland University Hospital Announce Clinical Trial of D-Serine for Modifying Parkinson’s Disease Progression
Jan. 20, 2026

SPARK NS and Haukeland University Hospital Announce Clinical Trial of D-Serine for Modifying Parkinson’s Disease Progression

Indeterminate GlobeNewswire
BioAge Announces Indication Expansion for Oral NLRP3 Inhibitor BGE-102, with Plans to Initiate Phase 1b/2a Proof-of-Concept Clinical Trial in Patients with Diabetic Macular Edema in Mid-2026
Jan. 20, 2026

BioAge Announces Indication Expansion for Oral NLRP3 Inhibitor BGE-102, with Plans to Initiate Phase 1b/2a Proof-of-Concept Clinical Trial in Patients with Diabetic Macular Edema in Mid-2026

Indeterminate GlobeNewswire
Polarean Expands Xenon MRI Platform into Cardiopulmonary Drug Development with Multi-Center PH-ILD Study
Jan. 20, 2026

Polarean Expands Xenon MRI Platform into Cardiopulmonary Drug Development with Multi-Center PH-ILD Study

Indeterminate GlobeNewswire
Propanc Biopharma Files New Provisional Patent Application for Methods of Producing Trypsinogen & Chymotrypsinogen with IP Australia
Jan. 20, 2026

Propanc Biopharma Files New Provisional Patent Application for Methods of Producing Trypsinogen & Chymotrypsinogen with IP Australia

Indeterminate GlobeNewswire
BrightInsight Strengthens Executive Leadership Team with Three Key Hires to Accelerate Global Growth and Innovation
Jan. 20, 2026

BrightInsight Strengthens Executive Leadership Team with Three Key Hires to Accelerate Global Growth and Innovation

Indeterminate GlobeNewswire
InStride Health and The Wharton School Showcase Successful AI Scribe Adoption for Improved Clinician Efficiency and Experience
Jan. 20, 2026

InStride Health and The Wharton School Showcase Successful AI Scribe Adoption for Improved Clinician Efficiency and Experience

Indeterminate GlobeNewswire
BrightInsight Announces Multi-Million Dollar Strategic Investment to Advance its AI-Enabled Medication Persistence and Adherence Solutions
Jan. 20, 2026

BrightInsight Announces Multi-Million Dollar Strategic Investment to Advance its AI-Enabled Medication Persistence and Adherence Solutions

Indeterminate GlobeNewswire
RenovoRx Expands RenovoCath® Commercial Adoption to Nine Active Cancer Centers Including City of Hope Cancer Center and Moffitt Cancer Center
Jan. 20, 2026

RenovoRx Expands RenovoCath® Commercial Adoption to Nine Active Cancer Centers Including City of Hope Cancer Center and Moffitt Cancer Center

Indeterminate GlobeNewswire
Radix Health Rebrands as Pivotal Health
Jan. 20, 2026

Radix Health Rebrands as Pivotal Health

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions